Host defense functions of M. tuberculosis lipoglycan

结核分枝杆菌脂聚糖的宿主防御功能

基本信息

  • 批准号:
    6537916
  • 负责人:
  • 金额:
    $ 30.42万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2001
  • 资助国家:
    美国
  • 起止时间:
    2001-07-15 至 2006-05-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (Adapted from the Applicant's Abstract): Tuberculosis (TB) is the leading cause of death by an infectious agent. Macrophages play a pivotal role in the control of Mycobacterium tuberculosis through the expression of nitric oxide (NO.) and TNFalpha. NO plays an important mycobactericidal role in murine TB and is increasingly recognized to be important in humans. The overall hypothesis of this proposal is that macrophages, by specific surface receptor(s), recognize mycobacterial cell wall products to initiate iNOS- and TNFa-induction. Hence, the focus of this proposal is to: i) determine the receptor and signaling mechanisms which regulate iNOS and TNFa following exposure to the mycobacterial cell wall component lipoarabinomannan (ManLAM) and ii) to determine the significance of each of these components in an in vitro model of infection. Based on experiments showing that macrophages from the Toll-like receptor 4 (TLR4)-mutant C3H/HeJ mice produced significantly lower levels of NO than TLR4-intact C3H/HeN macrophages in response to IFNg + ManLAM, we hypothesize that ManLAM engages a TLR to induce iNOS-NO*/ TNFa expression. Since non-mannose capped LAM (AraLAM) from M. smegmatis induced greater NO about expression than ManLAM, we hypothesize that ii) the exposed arabinose residues on ManLAM or AraLAM are the components of ManLAM that bind to its putative TLR. Since initial studies show that the mitogen-activated protein kinases (MAPKs) and NFkB signaling pathways regulate iNOS and TNFa expression, we hypothesize that the proximal kinase MAP/ERK kinase kinase (MEKK) is a pivotal regulator for ManLAM-induction of iNOS and TNFa. Lastly, because TLRs recognize pathogen-derived molecules and enhance host-defenses, we hypothesize that blocking one or more of the TLRs will enhance the growth of M. tuberculosis and inhibit NO* and TNFa expression. These hypotheses will be addressed by three specific aims: 1. To determine the ManLAM structures that mediate the induction of iNOS-NO*/TNFa and the receptor that mediates these ManLAM effects. 2. To investigate the role of the MAPK and NFkB signaling pathways in ManLAM- and other lipoglycan-induced iNOS-NO* and TNFa. 3. To elucidate the role of the TLRs, MAPK and NFkB signaling pathways, and ManLAM in controlling the growth of M. tuberculosis in mouse and human macrophages and to correlate effects on growth with NO* and TNFa expression.
描述(改编自申请人摘要):结核病(TB)是一种

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

EDWARD D CHAN其他文献

EDWARD D CHAN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('EDWARD D CHAN', 18)}}的其他基金

Establishing the Therapeutic Efficacy of Alpha-1-Antitrypsin and Enoxaparin Against COVID-19
确定 Alpha-1-抗胰蛋白酶和依诺肝素针对 COVID-19 的治疗效果
  • 批准号:
    10588400
  • 财政年份:
    2023
  • 资助金额:
    $ 30.42万
  • 项目类别:
How Does Nicotine Impair Macrophage Killing of Mycobacterium Tuberculosis?
尼古丁如何削弱巨噬细胞对结核分枝杆菌的杀伤作用?
  • 批准号:
    10060736
  • 财政年份:
    2017
  • 资助金额:
    $ 30.42万
  • 项目类别:
The role of T regulatory cells in cigarette smoke-induced susceptibility to tuberculosis
T 调节细胞在香烟烟雾诱导的结核病易感性中的作用
  • 批准号:
    9295969
  • 财政年份:
    2016
  • 资助金额:
    $ 30.42万
  • 项目类别:
Mechanistic study of the host defense functions of IL-32 in tuberculosis
IL-32在结核病中的宿主防御功能机制研究
  • 批准号:
    8244621
  • 财政年份:
    2011
  • 资助金额:
    $ 30.42万
  • 项目类别:
Mechanistic study of the host defense functions of IL-32 in tuberculosis
IL-32在结核病中的宿主防御功能机制研究
  • 批准号:
    8762407
  • 财政年份:
    2011
  • 资助金额:
    $ 30.42万
  • 项目类别:
Mechanistic study of the host defense functions of IL-32 in tuberculosis
IL-32在结核病中的宿主防御功能机制研究
  • 批准号:
    8422876
  • 财政年份:
    2011
  • 资助金额:
    $ 30.42万
  • 项目类别:
Host defense functions of M. tuberculosis lipoglycan
结核分枝杆菌脂聚糖的宿主防御功能
  • 批准号:
    6371131
  • 财政年份:
    2001
  • 资助金额:
    $ 30.42万
  • 项目类别:
Host defense functions of M. tuberculosis lipoglycan
结核分枝杆菌脂聚糖的宿主防御功能
  • 批准号:
    6902571
  • 财政年份:
    2001
  • 资助金额:
    $ 30.42万
  • 项目类别:
Host defense functions of M. tuberculosis lipoglycan
结核分枝杆菌脂聚糖的宿主防御功能
  • 批准号:
    6648381
  • 财政年份:
    2001
  • 资助金额:
    $ 30.42万
  • 项目类别:
Host defense functions of M. tuberculosis lipoglycan
结核分枝杆菌脂聚糖的宿主防御功能
  • 批准号:
    6758005
  • 财政年份:
    2001
  • 资助金额:
    $ 30.42万
  • 项目类别:

相似海外基金

Metabolism and physiological importance of L-arabinose in plants
L-阿拉伯糖在植物中的代谢和生理重要性
  • 批准号:
    16K07391
  • 财政年份:
    2016
  • 资助金额:
    $ 30.42万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Regulatory Mechanisms of the E. coli Arabinose Operon
大肠杆菌阿拉伯糖操纵子的调节机制
  • 批准号:
    7861198
  • 财政年份:
    2009
  • 资助金额:
    $ 30.42万
  • 项目类别:
Construction of efficient conversion system from L-arabinose to ethanol by Saccharomyces cerevisiae
酿酒酵母L-阿拉伯糖高效转化体系的构建
  • 批准号:
    18760592
  • 财政年份:
    2006
  • 资助金额:
    $ 30.42万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
D-arabinose synthesis in TB using Azorhizobium as a tool
使用固氮根瘤菌作为工具合成结核病中的 D-阿拉伯糖
  • 批准号:
    6708032
  • 财政年份:
    2003
  • 资助金额:
    $ 30.42万
  • 项目类别:
D-arabinose synthesis in TB using Azorhizobium as a tool
使用固氮根瘤菌作为工具合成结核病中的 D-阿拉伯糖
  • 批准号:
    6589461
  • 财政年份:
    2003
  • 资助金额:
    $ 30.42万
  • 项目类别:
D-arabinose synthesis in TB using Azorhizobium as a tool
使用固氮根瘤菌作为工具合成结核病中的 D-阿拉伯糖
  • 批准号:
    6848776
  • 财政年份:
    2003
  • 资助金额:
    $ 30.42万
  • 项目类别:
D-ARABINOSE SYNTHESIS AS A TARGET SITE FOR CHEMOTHERAPY
D-阿拉伯糖合成作为化疗的靶点
  • 批准号:
    6170509
  • 财政年份:
    1998
  • 资助金额:
    $ 30.42万
  • 项目类别:
D-ARABINOSE SYNTHESIS AS A TARGET SITE FOR CHEMOTHERAPY
D-阿拉伯糖合成作为化疗的靶点
  • 批准号:
    2661146
  • 财政年份:
    1998
  • 资助金额:
    $ 30.42万
  • 项目类别:
D-ARABINOSE SYNTHESIS AS A TARGET SITE FOR CHEMOTHERAPY
D-阿拉伯糖合成作为化疗的靶点
  • 批准号:
    2887764
  • 财政年份:
    1998
  • 资助金额:
    $ 30.42万
  • 项目类别:
FUNCTIONAL COMPARISON OF RHAMNOSE & ARABINOSE OPERONS
鼠李糖的功能比较
  • 批准号:
    2169010
  • 财政年份:
    1993
  • 资助金额:
    $ 30.42万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了